Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIFT: Gabapentin in Fibromyalgia
NCT00057278Phase 3Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in fibromyalgia (FM), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Mar 2003; status: completed.
02
Drugs
gabapentin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00057278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057278.